Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018563 · ClinicalTrials.gov registry record · Phase 2
An Open Label Extension Study of the Efficacy of MORAb-003
A Phase 2 study, sponsored by Morphotek.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT01018563 is a Phase 2 study that was terminated before completion, run by Morphotek. The registered enrollment target is 3 participants.
The verdict
NCT01018563, a Phase 2 study, was terminated before completion, sponsored by Morphotek.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
An open label extension of the MORAb-003-002 study in order to continue the active patients in the MORAb-003-002 study on maintenance MORAb-003 infusions after the main study is closed.
Interventions
- DRUG MORAb-003
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-01-13 |
| Est. Completion | 2013-03-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018563
The ClinicalTrials.gov registry entry for NCT01018563 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Morphotek, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MORAb-003 is the first listed.
NCT01018563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018563 about?
NCT01018563 is a clinical study titled "An Open Label Extension Study of the Efficacy of MORAb-003". An open label extension of the MORAb-003-002 study in order to continue the active patients in the MORAb-003-002 study on maintenance MORAb-003 infusions after the main study is closed.
What is the current status of trial NCT01018563?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2010-01-13. Estimated completion is 2013-03-05.
What interventions are being tested in trial NCT01018563?
The interventions under investigation include: MORAb-003 (DRUG).
Who is sponsoring clinical trial NCT01018563?
This trial is sponsored by Morphotek, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.